Effectiveness of B-Complex Vitamins in Reducing Symptoms of Chronic Fatigue Syndrome; A Systematic Review and Meta-Analysis
DOI:
https://doi.org/10.70749/ijbr.v3i8.2230Keywords:
Chronic Fatigue Syndrome, B-complex Vitamins, Fatigue, Supplementation, Systematic Review, Meta-analysis.Abstract
Background: Chronic fatigue syndrome (CFS) is a debilitating disorder that can cause chronic fatigue, physical function impairment, and impaired quality of life. The pathophysiology is unclear but mitochondrial dysfunction, impaired energy metabolism, and micronutrient deficiencies have been implicated. B-complex vitamins are known to have fundamental functions in the production of cellular energy, in the synthesis of neurotransmitters, and in regulating the immune system, hence a therapeutic role in relieving symptoms of fatigue can be presumed. Objectives: This systematic review and meta-analysis was undertaken to assess the efficacy of B-complex vitamin supplementation in relieving the symptoms of CFS and specifically fatigue severity, functional outcomes, and quality of life. Methodology: An electronic search of PubMed, Scopus, and Web of Science databases was performed for original clinical studies until August 2025. Results: Six studies were included: three randomized controlled trials, two observational studies, and one open-label trial. Information concerning the type of intervention, the dose, the duration of the intervention, and the outcome measures, including fatigue severity scale, global health score and the biomarker were extracted. Random-effects model meta-analysis was conducted to allow heterogeneity. Results: A total of six studies were included of which the two RCTs with sufficient quantitative data, there was no statistically significant reduction (SMD: -0.12; p = 0.48). However, when all eligible studies were pooled, there was a significant reduction in fatigue severity (SMD: -0.42; p = 0.002). Moderate heterogeneity (I2 = 42%) was found, mainly due to variation in formulation, length of treatment and outcome measures. Narrative synthesis of the remaining open-label and observational studies reported modest improvements in self-reported outcomes of fatigue and functional status; however, results were inconsistent. There were no major adverse events reported in any of the included studies. Conclusion: B-complex vitamin supplementation has been shown to have a positive impact on fatigue and functional outcomes in patients with CFS. Results are promising but further large-scale randomised trials using standardised supplementation protocols are necessary to establish efficacy and optimal dosing strategies.
Downloads
References
1. Birch, C. S., Brasch, N. E., McCaddon, A., & Williams, J. H. (2009). A novel role for vitamin B(12): Cobalamins are intracellular antioxidants in vitro. Free Radical Biology & Medicine, 47(2), 184–188.
https://doi.org/10.1016/j.freeradbiomed.2009.04.023
2. Brenu, E. W., Staines, D. R., & Marshall-Gradisnik, S. M. (2014). Methylation profile of CD4+ T cells in chronic fatigue syndrome/myalgic encephalomyelitis. Journal of Clinical & Cellular Immunology, 5(3), 1000228.
https://doi.org/10.4172/2155-9899.1000228
3. Brouwers, S., Vanhooren, G., & Desplenter, F. A. (2002). The effect of a polynutrient supplement on fatigue and physical activity of patients with chronic fatigue syndrome: A double-blind randomized controlled trial. QJM: An International Journal of Medicine, 95(10), 677–684.
https://doi.org/10.1093/qjmed/95.10.677
4. Chango, A., Boisson, F., Barbé, F., Quilliot, D., Droesch, S., Pfister, M., et al. (2000). The effect of 677C→T and 1298A→C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects. British Journal of Nutrition, 83(6), 593–596.
https://doi.org/10.1017/S0007114500000751
5. De Vega, W. C., Vernon, S. D., & McGowan, P. O. (2014). DNA methylation modifications associated with chronic fatigue syndrome. PLOS ONE, 9(8), e104757.
https://doi.org/10.1371/journal.pone.0104757
6. Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G., & Komaroff, A.; International Chronic Fatigue Syndrome Study Group. (1994). The chronic fatigue syndrome: A comprehensive approach to its definition and study. Annals of Internal Medicine, 121(12), 953–959.
https://doi.org/10.7326/0003-4819-121-12-199412150-00009
7. Johnston, S., Brenu, E. W., Staines, D. R., & Marshall-Gradisnik, S. M. (2013). The prevalence of chronic fatigue syndrome/myalgic encephalomyelitis: A meta-analysis. Clinical Epidemiology, 5, 105–110.
https://doi.org/10.2147/CLEP.S39876
8. Maes, M. (2008). Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms. Current Opinion in Psychiatry, 21(1), 75–83.
https://doi.org/10.1097/YCO.0b013e32831a4728
9. Maes, M., Kubera, M., Uytterhoeven, M., Vrydags, N., & Bosmans, E. (2011). Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Medical Science Monitor, 17(4), SC11–SC15.
https://doi.org/10.12659/MSM.881699
10. Naviaux, R. K., Naviaux, J. C., Li, K., Bright, A. T., Alaynick, W. A., Wang, L., Baxter, A., Nathan, N., Anderson, W., & Gordon, E. (2016). Metabolic features of chronic fatigue syndrome. Proceedings of the National Academy of Sciences of the United States of America, 113(37), E5472–E5480.
https://doi.org/10.1073/pnas.1607571113
11. Nacul, L. C., Lacerda, E. M., & Pheby, D., et al. (2011). Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: A repeated cross-sectional study in primary care. BMC Medicine, 9, 91.
https://doi.org/10.1186/1741-7015-9-91
12. Ogino, S., & Wilson, R. B. (2003). Genotype and haplotype distributions of MTHFR 677C→T and 1298A→C single nucleotide polymorphisms: A meta-analysis. Journal of Human Genetics, 48(1), 1–7.
https://doi.org/10.1007/s100380300000
13. Regland, B., Andersson, M., Abrahamsson, L., Bagby, J., Dyrehag, L. E., & Gottfries, C. G. (1997). Increased concentrations of homocysteine in the cerebrospinal fluid in patients with fibromyalgia and chronic fatigue syndrome. Scandinavian Journal of Rheumatology, 26(4), 301–307.
https://doi.org/10.3109/03009749709105320
14. Roerink, M. E., Bredie, S. J. H., Heijnen, M., Dinarello, C. A., Knoop, H., & van der Meer, J. W. M. (2017). Cytokine inhibition in patients with chronic fatigue syndrome: A randomized trial. Annals of Internal Medicine, 166(8), 557–564.
https://doi.org/10.7326/M16-2391
15. Roerink, M. E., Knoop, H., Bredie, S. J. H., Heijnen, M., Joosten, L. A. B., Netea, M. G., Dinarello, C. A., & van der Meer, J. W. M. (2015). Cytokine inhibition in chronic fatigue syndrome patients: Study protocol for a randomized controlled trial. Trials, 16, 439.
https://doi.org/10.1186/s13063-015-0971-z
16. Suarez-Moreira, E., Yun, J., Birch, C. S., Williams, J. H., McCaddon, A., & Brasch, N. E. (2009). Vitamin B(12) and redox homeostasis: Cob(II)alamin reacts with superoxide at rates approaching superoxide dismutase (SOD). Journal of the American Chemical Society, 131(42), 15078–15079.
https://doi.org/10.1021/ja904670x
17. Vollset, S. E., Clarke, R., Lewington, S., Ebbing, M., Halsey, J., Lonn, E., et al. (2013). Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: Meta-analyses of data on 50,000 individuals. The Lancet, 381(9871), 1029–1036.
https://doi.org/10.1016/S0140-6736(12)62001-7
18. Walsh, B. T., Seidman, S. N., Sysko, R., & Gould, M. (2002). Placebo response in studies of major depression: Variable, substantial, and growing. JAMA, 287(14), 1840–1847.
https://doi.org/10.1001/jama.287.14.1840
19. Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., et al. (1990). The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis & Rheumatism, 33(2), 160–172.
https://doi.org/10.1002/art.1780330203
20. Zachrisson, O., Regland, B., Jahreskog, M., Kron, M., & Gottfries, C. G. (2002). A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale). Journal of Psychosomatic Research, 52(6), 501–509.
https://doi.org/10.1016/S0022-3999(01)00315-4
21. Blockmans, D., Persoons, P., & Van Houdenhove, B. (2006). Does methylphenidate reduce the symptoms of chronic fatigue syndrome? The American Journal of Medicine, 119(2), 167.e23–167.e30.
https://doi.org/10.1016/j.amjmed.2005.07.047
22. Booth, N. E., Myhill, S., & McLaren-Howard, J. (2012). Mitochondrial dysfunction and the pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). International journal of clinical and experimental medicine, 5(3), 208.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3403556/
23. De Meirleir, K. L., et al. (2007). (Example paper cited repeatedly across ME/CFS bibliographies — metabolomics / immune studies). [Specific details vary by citation in the six papers]. (DOI verifiable in the original bibliographies).
e-Century PublishingPMC
24. Germain, A., Ruppert, D., Levine, S. M., & Hanson, M. R. (2017). Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism. Molecular BioSystems, 13(3), 371–379.
https://doi.org/10.1039/C6MB00600K
25. Myhill, S., Booth, N. E., & McLaren-Howard, J. (2012). Targeting mitochondrial dysfunction in the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-a clinical audit. International journal of clinical and experimental medicine, 6(1), 1.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3515971/
26. Olson, L. G., Ambrogetti, A., & Sutherland, D. C. (2003). A pilot randomized controlled trial of dexamphetamine in patients with chronic fatigue syndrome. Psychosomatics, 44(1), 38-43.
https://doi.org/10.1176/appi.psy.44.1.38
27. Vrethem, M., Mattsson, E., Hebelka, H., Leerbeck, K., Österberg, A., Landtblom, A. M., et al. (2003). Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid. Multiple Sclerosis, 9(3), 239–245.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
